|
Osipov E.V., Batyushin M.M., Nalgieva Z.M.
Impaired sleep-wakefulness and quality of life in patients with arterial hypertension and chronic kidney disease
|
№3 / 2022
|
|
Mikhailova Z.D., Omarova Yu.V.
Kidney damage in patients with CHF and obesity (local register data)
|
№3 / 2022
|
|
Murkamilov I.T., Sabirov I.S., Murkamilova Zh.A., Fomin V.V., Sabirova A.I., Kudaybergenova I.O., Yusupov F.A., Maanaev T.I.
The prevalence of risk factors for cerebrovascular diseases in patients with chronic kidney disease and renal failure
|
№3 / 2022
|
|
Berdichevsky V.B., Zmurov V.A., Romanova A.V., Rasulov F.R., Khilkevich S.V., Boldyrev A.L., Gonyaev A.R., Bichenova A.G.
Non-diabetic glucosuria in patients with primary chronic pyelonephritis
|
№3 / 2022
|
|
Komissarov K.S., Krasko O.V., Dmitrieva M.V., Letkovskaja T.A., Lugovskaya M.A., Kalinovskaya J.I., Pilotovich V.S.
IgA-nephropathy in Belarusian cohort. Сlinical and pathological peculiarities, factors, associated with unfavorable outcome
|
№3 / 2022
|
|
Rebrov A.P., Grigoryeva E.V., Petrov G.S., Polidanov M.A., Kondrashkin I.E., Blokhin I.S., Tyapkina D.A., Boroday A.A.
Patients receiving renal replacement therapy with hemodialysis and taking NSAIDs during the COVID-19 pandemic
|
№3 / 2022
|
|
Zhmurov D.V., Zhmurov V.A., Petrov I.M., Petelina T.I., Gapon L.I., Yaroslavskaya E.I., Petrova Yu.A., Zhmurova E.A. , Ermakova A.A., Ermakova P.A.
Post-COvid Cytokine profile and cardiovascular status in patients with chronic kidney disease after COVID-19
|
№3 / 2022
|
|
Shutov E.V., Bolshakov S.A., Kotlyarova G.V., Emelyanova E.B., Sorokoletov S.M., Dolidze D.D.
Evaluation of humoral response to Gam-Covid-Vac (Sputnik V) vaccination against COVID-19 in patients on hemodialysis and peritoneal dialysis
|
№3 / 2022
|
|
Shutov E.V.
Expert opinion. Low-protein high caloric enteral nutrition «Fresubin Renal» in nephrology
|
№3 / 2022
|
|
N.A. Mikhailova
Expert judgement «Correction of hyperkalemia in CKD. Modern possibilities and therapeutic relevance»
|
№2 / 2022
|
|
Expert Council «Therapy of mineral and bone disorders in CKD. Sevelamer carbonate: from control of hyperphosphatemia to pleiotropic effects»
|
№2 / 2022
|
|
Sh.S. Abdullaev, R.Sh. Igamberdieva
Prevention of thromboembolic complications in patients with end-stage kidney disease and atrial fibrillation
|
№2 / 2022
|
Русский
